Press Releases

Date	Title
3/15/19	Pulse Biosciences Grants Equity Incentive Awards to New Employees
3/1/19	Pulse Biosciences Announces Late Breaking Oral Presentation of Sebaceous Hyperplasia Study Results at the 2019 AAD Annual Meeting
2/28/19	Pulse Biosciences Submits 510(K) to U.S. FDA for CellFX™ System
2/15/19	Pulse Biosciences Grants Equity Incentive Awards to New Employees
2/7/19	Pulse Biosciences Quarterly Investor Conference Call
1/28/19	Pulse Biosciences to Report Fourth Quarter and Full Year 2018 Operational Highlights and Financial Results
1/17/19	Pulse Biosciences Announces Two Appointments Focused on CellFX™ Commercialization: Promotion of Edward Ebbers and Addition of Robert Tyson
1/15/19	Pulse Biosciences Grants Equity Incentive Awards to New Employees
1/7/19	Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the Face
12/17/18	Pulse Biosciences Grants Equity Incentive Awards to New Employees

Keyword Search